3[3]Rajiv A.Add-on angiotensin receptor blockade with maximized ACE inhibition.Kidney Int,2001,59:2282
4[4]Karin JD,Zemin C,Alison J.Role of hyperlipidemia in progressive renal disease:focus on diabetic nephropathy.Kidney Int,1999,56(suppl71):S31
5[5]Hung CC,Jinn YG,Shyi JS,et al.Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein.Kidney Int,2001,59(suppl):S124
6[6]Park YS,Gudarro C,Kim Y,et al.Lovasatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.Am J Kidney Dis,1998,31:190
7[7]Tamotsu Y,Kazunori U,Yuichi M,et al.Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy.Kidney Int,1999,56(suppl71):S178
8[8]Antonio C,Anna M,Franceschina M,et al.Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.Diabetes,2000,49:2170
9[9]Hisaya T,Hiroyuki I,Sho I,et al.Protective effect of D-α-Tocophrol on the function of human mesangial cells exposed to high glucose concentrations.Metabolism,1997,46(7):779
10[10]Allison AE.Interstitial fibrosis in hypercholesterolemic rats:role of oxidation,matrix synthesis,and proteolytic cascades.Kidney Int,1998,53:1182
